Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($) $ in Thousands	Common Stock Outstanding [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Total
Balance (in shares) at Dec. 31, 2023	2,227,516
Balance at Dec. 31, 2023	$ 33	$ 177,300	$ (146,396)	$ (9)	$ 30,928
Stock-based compensation	0	456	0	0	456
Consolidated net loss	0	0	(6,425)	0	(6,425)
Cumulative translation adjustment	0	0	0	(9)	(9)
Net loss	$ 0	0	(6,425)	0	(6,425)
Balance (in shares) at Mar. 31, 2024	2,311,536
Issuance of common stock to consultants (in shares)	6,834
Issuance of common stock to consultants	$ 0	37	0	0	37
Reverse stock split (in shares)	77,186
Reverse stock split	$ (31)	31	0	0	0
Balance at Mar. 31, 2024	$ 2	177,824	(152,821)	(18)	24,987
Balance (in shares) at Dec. 31, 2023	2,227,516
Balance at Dec. 31, 2023	$ 33	177,300	(146,396)	(9)	30,928
Consolidated net loss					(12,440)
Net loss					(12,440)
Balance (in shares) at Jun. 30, 2024	2,560,785
Balance at Jun. 30, 2024	$ 3	178,252	(158,836)	(10)	19,409
Balance (in shares) at Dec. 31, 2023	2,227,516
Balance at Dec. 31, 2023	$ 33	177,300	(146,396)	(9)	30,928
Consolidated net loss					(19,464)
Cumulative translation adjustment					13
Net loss					(19,464)
Balance (in shares) at Sep. 30, 2024	3,001,895
Balance at Sep. 30, 2024	$ 3	183,264	(165,860)	4	17,411
Balance (in shares) at Mar. 31, 2024	2,311,536
Balance at Mar. 31, 2024	$ 2	177,824	(152,821)	(18)	24,987
Warrants exercised (in shares)	229,506
Warrants exercised	$ 1	0	0	0	1
Stock-based compensation	0	453	0	0	453
Consolidated net loss	0	0	(6,015)	0	(6,015)
Cumulative translation adjustment	$ 0	0	0	8	8
Common stock issued upon vesting of restricted stock units (net of taxes) (in shares)	19,743
Common stock issued upon vesting of restricted stock units (net of taxes)	$ 0	(25)	0	0	(25)
Net loss	$ 0	0	(6,015)	0	(6,015)
Balance (in shares) at Jun. 30, 2024	2,560,785
Balance at Jun. 30, 2024	$ 3	178,252	(158,836)	(10)	19,409
Warrants exercised (in shares)	157,368
Warrants exercised	$ 0	0	0	0	0
Issued for cash - sale of common stock, pre-funded and common warrants (in shares)	283,000
Issued for cash - sale of common stock, pre-funded and common warrants	$ 0	0	0	0	0
Stock-based compensation	0	353	0	0	353
Consolidated net loss	0	0	(7,024)	0	(7,024)
Equity warrants issued	0	4,660	0	0	4,660
Cumulative translation adjustment	$ 0	0	0	14	14
Common stock issued upon vesting of restricted stock units (net of taxes) (in shares)	742
Common stock issued upon vesting of restricted stock units (net of taxes)	$ 0	(1)	0	0	(1)
Net loss	$ 0	0	(7,024)	0	(7,024)
Balance (in shares) at Sep. 30, 2024	3,001,895
Balance at Sep. 30, 2024	$ 3	183,264	(165,860)	4	17,411
Balance (in shares) at Dec. 31, 2024	3,378,895
Balance at Dec. 31, 2024	$ 3	183,690	(172,444)	(41)	11,208
Warrants inducement exercised (in shares)	5,828,570
Warrants inducement exercised	$ 6	0	0	0	6
Warrants exercised (in shares)	3,770,029
Warrants exercised	$ 4	0	0	0	4
Issued for cash - sale of common stock, pre-funded and common warrants (in shares)	1,150,000
Issued for cash - sale of common stock, pre-funded and common warrants	$ 1	0	0	0	1
Stock-based compensation	0	485	0	0	485
Consolidated net loss	0	0	(5,904)	0	(5,904)
Equity warrants issued	0	7,988	0	0	7,988
Cumulative translation adjustment	0	0	0	3	3
Net loss	$ 0	0	(5,904)	0	(5,904)
Balance (in shares) at Mar. 31, 2025	14,127,494
Balance at Mar. 31, 2025	$ 14	192,163	(178,348)	(38)	13,791
Balance (in shares) at Dec. 31, 2024	3,378,895
Balance at Dec. 31, 2024	$ 3	183,690	(172,444)	(41)	11,208
Consolidated net loss					(23,713)
Net loss					(23,713)
Balance (in shares) at Jun. 30, 2025	30,207,494
Balance at Jun. 30, 2025	$ 30	192,580	(196,157)	(38)	(3,585)
Balance (in shares) at Dec. 31, 2024	3,378,895
Balance at Dec. 31, 2024	$ 3	183,690	(172,444)	(41)	11,208
Consolidated net loss					(49,112)
Cumulative translation adjustment					(3)
Net loss					(49,112)
Balance (in shares) at Sep. 30, 2025	49,498,576
Balance at Sep. 30, 2025	$ 49	194,631	(221,556)	(44)	(26,920)
Balance (in shares) at Mar. 31, 2025	14,127,494
Balance at Mar. 31, 2025	$ 14	192,163	(178,348)	(38)	13,791
Warrants exercised (in shares)	6,107,974
Warrants exercised	$ 6	0	0	0	6
Issued for cash - sale of common stock, pre-funded and common warrants (in shares)	9,972,026
Issued for cash - sale of common stock, pre-funded and common warrants	$ 10	0	0	0	10
Stock-based compensation	0	417	0	0	417
Consolidated net loss	0	0	(17,809)	0	(17,809)
Net loss	$ 0	0	(17,809)	0	(17,809)
Balance (in shares) at Jun. 30, 2025	30,207,494
Balance at Jun. 30, 2025	$ 30	192,580	(196,157)	(38)	(3,585)
Warrants inducement exercised (in shares)	16,216,216
Warrants inducement exercised	$ 16	1,748	0	0	1,764
Warrants exercised (in shares)	2,996,192
Warrants exercised	$ 3	0	0	0	3
Stock-based compensation	0	303	0	0	303
Consolidated net loss	0	0	(25,399)	0	(25,399)
Cumulative translation adjustment	$ 0	0	0	(6)	(6)
Common stock issued upon vesting of restricted stock units (net of taxes) (in shares)	19,889
Common stock issued upon vesting of restricted stock units (net of taxes)	$ 0	0	0	0	0
Issuance of common stock in connection with a consulting agreement (in shares)	58,785
Issuance of common stock in connection with a consulting agreement	$ 0	0	0	0	0
Net loss	$ 0	0	(25,399)	0	(25,399)
Balance (in shares) at Sep. 30, 2025	49,498,576
Balance at Sep. 30, 2025	$ 49	$ 194,631	$ (221,556)	$ (44)	$ (26,920)